Institut de Cancérologie de L'Ouest
Angers, 49055, France
NCT Number: NCT04675814
The objective of this study is to evaluate the effects of regular physical practice on fatigue, quality of life and kinesiophobia in patients treated at the ICO in Angers, regardless of the type of cancer and the type of treatment.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Angers, 49055, France
The objective of this study is to evaluate the effects of regular physical practice on fatigue, quality of life and kinesiophobia in patients treated at the ICO in Angers, regardless of the type of cancer and the type of treatment.
A 12-week Adapted Physical Activity program (APA) is proposed to patients included in the study with an assessment of fatigue, quality of life, level of physical activity and kinesiophobia (fear of movement) at the beginning of the study.
A second assessment of fatigue and quality of life will be done during the 6-week management.
At the end of the program, a final evaluation of fatigue, quality of life and kinesiophobia will be done.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Adults participating in the APA program at ICO during the first semester of 2020, regardless of cancer type and ongoing treatment (chemotherapy, radiotherapy, hormone therapy, immunotherapy). The APA program duration is : 12 weeks
Time frame: 12 weeks
Describe the evolution of the quality of life of patients being treated for their cancer pathology at the ICO site in Angers, and participating in the 12-week adapted physical activity program at ICO.
Quality of life is measured with the FACIT-F Fatigue and Quality of Life Questionnaire. The questionnaire is structured into five sections, each containing between 6 and 13 items. In total, it includes 40 items, each scored from 0 to 4:
0 - Not at all
Time frame: 12 weeks
The number of sessions is planned by the APA coach at the beginning of the APA program. The number of performed sessions is measured.
Time frame: 12 weeks
Kinesiophobia is measured with the TAMPA Scale for Kinesiophobia (TSK-CF). This scale assesses the kinesiophobia index presented by the patient at the time of the assessment. The higher the score, the greater the level of kinesiophobia. Total score range: 17 to 68. Higher scores indicate greater fear of movement.
A score ≥ 40 is considered significant kinesiophobia.
Time frame: Week 0
The level of physical activity (PA) is assessed using the GPAQ questionnaire. The questionnaire consists of 16 items. Physical activity is expressed in MET-minutes per week (Metabolic Equivalent of Task), calculated from reported activity.
Based on the score, three profiles are defined:
High
Institut Cancerologie de l'Ouest
Other
Prospective Evaluation of the Impact on Patients' Quality of Life of a 12-Week Adapted Physical Activity Program (APA) at Institut de Cancerologie de l'Ouest (ICO)
Acronym: APA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06417970
Anxiety Disorders, Kinesiophobia
Isparta, Turkey (Türkiye)
View Trial DetailsNCT05218993
ACL Injury, Anterior Cruciate Ligament Injuries
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07726836
Sports Physical Therapy
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07726849
Sports Physical Therapy
Lahore, Punjab Province, Pakistan
View Trial Details